ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Natural Remedies for the Prevention of Dry Eyes

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

Resveratrol supplementation improves arterial stiffness in type 2 diabetics

CoQ10's Potential Capabilities for Your Health

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

Testosterone replacement therapy associated with improved urinary, sexual function

8 Chia Seed Recipes

 
Print Page
Email Article

ONE WEEK LATER: Outrage Over Suppression of FDA-NIH's Positive XMRV Paper Despite July 1 Publication of Negative CDC Paper

  [ 157 votes ]   [ 3 Comments ]
www.ProHealth.com • July 6, 2010


On Thursday, July 1...

The US Department of Health & Human Services chose to allow publication of the CDC’s negative paper(1) (reporting failure to find XMRV in any CFS patients' blood) while the NIH-FDA’s positive paper reporting XMRV in CFS blood samples - which was to be published by Proceedings of the National Academy of Sciences - was cast into limbo.


"CDC Team's XMRV-Chronic Fatigue Syndrome Paper is Out," wrote Wall Street Journal health reporter Amy Dockser Marcus at 5:03 PM EST, July 1. At the same time, she noted, NIH spokesman John T. Burklow said "the FDA-NIH paper has been accepted for publication but that the authors decided to pull it back to conduct additional experiments. Publication will depend on how long it takes to fully address questions. 'It’s a matter of getting it right,' he says."

Dockser Marcus also quoted WPI President Annette Whittemore, who urged immediate publication of the FDA-NIH paper, to "let the science speak for itself."

Note, in the Reader Comments on the WSJ article: a quote from Suzanne Vernon, PhD, Scientific Director of the CFIDS Association, faults the CDC study methods, stating, "The explanation for not finding XMRV in these samples is simple - this was a study designed to not detect XMRV, using a hodge-podge sample set."

To read Dr. Vernon's full critique of the CDC study, see her article "Blood from a Stone," published July 1 on the CFIDS Association website.

On Friday, July 2...

According to a Whittemore Peterson statement posted July 2, "In September 2009, WPI sent the CDC 20 confirmed positive samples and the appropriate methodology to help them develop a clinically validated test. However, this team chose not to do this."

On Saturday, July 3...

Mindy Kitei posted a "Q&A with CDC Scientists" on her CFS Central blog site. She asked pointed questions of Bill Switzer, lead author of the negative paper, and CDC viral diseases division director Steve Monroe via an e-mail exchange handled by a CDC press office middleman. She received deflective non-answers in return.

On Tuesday, July 6...

Kitei reported more damning intelligence. The FDA/NIH paper had not only been accepted for publication by PNAS but was edited and already in galley pages for proofreading when it was pulled, Kitei reportedly learned from HHS insider "sources." Who also informed Kitei that blocking the paper was ultimately an HHS decision made at the CDC's request, and advised, "HHS can keep any government study from being published, no matter how solid."

See also Cort Johnson's play-by-play coverage on the Phoenix Rising Website: the July 6 post being “XMRV SampleGate at the CDC?”

Patients urged to support efforts to explore XMRV further. As Dr. Charles Lapp stated July 6 in his Hunter-Hopkins Center ME-Newsletter:

“So the XMRV issue remains controversial and “up in the air” much as the retroviral issue was in the late 1980’s when we first discovered retroviruses in PWCs. Research was stifled at that time by opposing factions, and it has taken over 20 years and the resources of the Whittemore-Peterson Institute to bring this intriguing possibility back to light. We urge patients everywhere to support efforts to explore XMRV further. Ways you can help are:

• Donate a specimen of your precious blood to the SolveCFS BioBank. Click here for details.

• Support the CFIDS Association of America. This group has worked tirelessly for almost three decades to promote scientific research about Chronic Fatigue Syndrome.

• Donate to the Whittemore-Peterson Institute so that they can pursue this important lead to the bitter end.

On Wednesday, July 8...

Mindy Kitei reports she emailed the NIH press officer "asking about getting a statement from the HHS officials who put the hold on the FDA/NIH paper." He responded that he hoped to have an answer "ASAP." Nothing yet. Regarding patients' questions about how to effect change, Kitei reviews the 1996 CDC financial improprieties scandal and invites patients who contracted ME/CFS after a blood transfusion to contact her.

On Friday, July 9...

The FDA/NIH paper will be released "within weeks," according to the CFIDS Association. Specifically, a post on their Facebook page notes that "The researchers have conducted additional experiments as requested by the reviewers and their paper is expected to be published in the Proceedings of the National Academy of Sciences within weeks." Though no source was cited, the CAA later posted that "The information comes from several well-informed people close to the study with whom we are in regular contact."

If you're like us, you may want to attend and ask questions in the CAA's July 15 XMRV webinar.

____

1. Following is an abstract of the CDC paper, which reports their failure to find XMRV in CFS patients’ blood, published online July 1 by the journal Retrovirology. A link to the full text article is included.

* * * *

Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States – Source: Retrovirology, Jul 1, 2010

William M Switzer, et al.

[Note: To view a pdf of the article, click here.]

Background: XMRV, a xenotropic murine leukemia virus (MuLV)-related virus, was recently identified by PCR testing in 67% of persons with chronic fatigue syndrome (CFS) and in 3.7% of healthy persons from the United States. To investigate the association of XMRV with CFS we tested blood specimens from 51 persons with CFS and 56 healthy persons from the US for evidence of XMRV infection by using serologic and molecular assays. Blinded PCR and serologic testing were performed at the US Centers for Disease Control and Prevention (CDC) and at two additional laboratories.

Results: Archived blood specimens were tested from persons with CFS defined by the revised 1994 CDC case definition and matched healthy controls from Wichita, Kansas and metropolitan, urban, and rural Georgia populations.

Serologic testing at CDC utilized a Western blot (WB) assay that showed excellent sensitivity to MuLV and XMRV polyclonal or monoclonal antibodies, and no reactivity on sera from 121 US blood donors or 26 HTLV-and HIV-infected sera. Plasma from 51 CFS cases and plasma from 53 controls were all WB negative. Additional blinded screening of the 51 cases and 53 controls at the Robert Koch Institute using an ELISA employing recombinant Gag and Env XMRV proteins identified weak seroreactivity in one CFS case and a healthy control, which was not confirmed by immunofluorescence.

PCR testing at CDC employed a gag and a pol nested PCR assay with a detection threshold of 10 copies in 1 ug of human DNA. DNA specimens from 50 CFS patients and 56 controls and 41 US blood donors were all PCR-negative. Blinded testing by a second nested gag PCR assay at the Blood Systems Research Institute was also negative for DNA specimens from the 50 CFS cases and 56 controls.
Conclusions

We did not find any evidence of infection with XMRV in our U.S. study population of CFS patients or healthy controls by using multiple molecular and serologic assays. These data do not support an association of XMRV with CFS.

Source: Retrovirology, Jul 1, 2010; 7:57. doi:10.1186/1742-4690-7-57, by Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W.




Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® Energy NADH™ 12.5mg


Article Comments Post a Comment

Excellent Info
Posted by: Elisa
Jul 1, 2010
Thanks for keeping us up to date! Excellent reporting! Elisabeth
Reply Reply

Excellent de-bunking
Posted by: IanH
Jul 2, 2010
The history of this illness will prove to be an outstanding example of political mischief.
Reply Reply

 
Polital Mischief,,,,
Posted by: Shirl_M
Jul 7, 2010
I have been saying that for some time now, since this illness is sooo very strange... as is the fibro that often goes with it... I you would, could you be a bit more specific in your meaning, to see if we are "on the same page" as it were? Thank You,

 

 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map